Real World Study Using Comprehensive Genomic Data on the Next Treatment Decision Making in Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Clinical Trials Related to Novartis
Related studies linked through entity extraction aliases.
Study of the Effects of Overfeeding on Glucocorticoids in Lean and Obese Subjects
- Status
- COMPLETED
- Phase
- N/A
Pre-vitrectomy Intravitreal Ranibizumab for Patients With Proliferative Diabetic Retinopathy Combined With Diabetic Macular Edema
- Status
- UNKNOWN
- Phase
- PHASE4
Crizanlizumab for Treating COVID-19 Vasculopathy
- Status
- COMPLETED
- Phase
- PHASE2
Ruxolitinib in the Treatment of Covid-19
- Status
- UNKNOWN
- Phase
- PHASE2
Heart Failure in Norway: Clinical Characteristics, Mortality and Health Care Resource Use
- Status
- UNKNOWN
- Phase
- N/A
Canakinumab in Covid-19 Cardiac Injury (The Three C Study)
- Status
- COMPLETED
- Phase
- PHASE2
Adagrasib in Combination With TNO155 in Patients With Cancer (KRYSTAL 2)
- Status
- COMPLETED
- Phase
- PHASE1
French Register Of Patients With Hemopathy Eligible For CAR-T Cell Treatment (DESCAR-T)
- Status
- RECRUITING
- Phase
- N/A
Ribociclib&Belinostat In Patients w Metastatic Triple Neg Breast Cancer & Recurrent Ovarian Cancer w Response Prediction By Genomics
- Status
- RECRUITING
- Phase
- PHASE1
Study to Evaluate the Effect of Metformin in the Prevention of HG in HR[+]/HER2[-] PIK3CA-mut Advanced BC Patients
- Status
- COMPLETED
- Phase
- PHASE2
The Effect of Xiidra on Comfort and Dryness in Symptomatic Contact Lens Wearers
- Status
- COMPLETED
- Phase
- PHASE4
Intravitreal Brolucizumab in Neovascular Age-related Macular Degeneration With Limited Response to Aflibercept
- Status
- TERMINATED
- Phase
- PHASE4
Secukinumab for the Inflammatory Phase of Pyoderma Gangrenosum
- Status
- WITHDRAWN
- Phase
- PHASE2
Anti-inflammatory Effects Glycopyrronium
- Status
- COMPLETED
- Phase
- PHASE3
A Phase II, Open-Label, Study of Subcutaneous Canakinumab, an Anti-IL-1β Human Monoclonal Antibody, for Patients With Low or Int-1 Risk IPSS/IPSS-R Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trial to Assess The Efficacy and Safety of the Combination of Tisagenlecleucel And Ibrutinib in Mantle Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Ribociclib and Spartalizumab in R/M HNSCC
- Status
- UNKNOWN
- Phase
- PHASE1
ESR1 Mutations in Asian ER+ Metastatic Breast Cancer on Hormonal Therapy-based Treatments
- Status
- UNKNOWN
- Phase
- N/A
Siltuximab and Spartalizumab in Patients With Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2